H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
LCH III is an international, multicentric, prospective clinical study comprised of:
- a randomized clinical trial for multisystem "RISK" patients and
- a randomized clinical trial for multisystem "LOW RISK" patients and
- a pilot study for patients with single system MFB and localized "SPECIAL SITES"